Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity 4DMedical Limited ABN/ARBN Financial year ended: 31 161 684 831 30 June 2026 Our corporate governance...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from 4DMedical
- FY26 Annual Report
- Initial Director's Interest Notice - CJ
- Board transition and key personnel appointments
- Ceasing to be a substantial holder
- Application for quotation of securities - 4DX
Later from 4DMedical
- Notice of Annual General Meeting/Proxy Form
- Becoming a substantial holder
- Notification of cessation of securities - 4DX
- Addendum to 2026 Notice of Annual General Meeting
- Notice of 2026 Annual General Meeting - Clarification
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical